🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Autologous monocyte-derived dendritic cells pulsed with tumor lysate (PV-00...
Status
Unknown
Location
Multiple Locations
Start Date
2024-04-01
Trial ID
NCT03803397
Treatments Being Tested
Background: Sixteen melanoma patients (1 stage IIC, 8 stage III, and 7 stag...
Status
Completed
Location
Instituto Médico Alexander Fleming
Start Date
2004-10
Trial ID
NCT00515983
Treatments Being Tested
This study aims to determine if the vacccine can be used safely in patients...
Status
Completed
Location
BIDMC
Start Date
2000-07
Trial ID
NCT00626860
Treatments Being Tested
The aim of the study is to show if vaccination with autologous dendritic ce...
Status
Completed
Location
Department of Oncology, Copenhagen University Hospital, Herlev
Start Date
2004-09
Trial ID
NCT00197912
Treatments Being Tested
A Phase I vaccination trial in patients suffering from recently diagnosed m...
Status
Completed
Location
University Hospital Erlangen Dept. of Dermatology
Start Date
2020-09-24
Trial ID
NCT04335890
Treatments Being Tested
The purpose of this study is to find out what effects (good and bad) immuno...
Status
Terminated
Location
H. Lee Moffitt Cancer Center and Research Institute
Start Date
2018-03-15
Trial ID
NCT03406715
Treatments Being Tested
Current therapeutic approaches available for patients with advanced-stage m...
Status
Completed
Location
Hillman Cancer Center
Start Date
2014-05-16
Trial ID
NCT01876212
Treatments Being Tested
RATIONALE: Vaccines made by inserting a laboratory-treated gene into a pers...
Status
Completed
Location
Jonsson Comprehensive Cancer Center at UCLA
Start Date
2002-03
Trial ID
NCT00039325
Treatments Being Tested
RATIONALE: Vaccines made from a patient's dendritic cells may make the body...
Status
Unknown
Location
Massachusetts General Hospital
Start Date
2004-03
Trial ID
NCT00085397
In this study, a melanoma vaccine (5 melanoma peptides) is given with eithe...
Status
Completed
Location
NYU Clinical Cancer Center
Start Date
2005-07
Trial ID
NCT00124124
Treatments Being Tested